Guido Rovera

University of Turin

Papers

1

Total Citations

12

H-Index

1

About

Guido Rovera is a pioneering figure in the field of urologic oncology and nuclear medicine, with a primary focus on advancing precision surgery for prostate cancer. His key research areas include robot-assisted radioguided surgery, intraoperative imaging, and the clinical application of PSMA-targeted tracers. Rovera’s most notable contribution is the development and validation of PSMA-radioguided surgery, a technique that uses a PET-CT specimen imager to assess surgical margins and detect nodal metastases in real time during robotic prostatectomy. His landmark 2023 case report, which has garnered 12 citations, demonstrated the feasibility of this approach in three patients, offering a novel method to reduce positive margins and improve oncologic outcomes. This work bridges the gap between diagnostic imaging and surgical precision, positioning Rovera as a leader in theranostics and image-guided interventions. His research has significant implications for personalized cancer care, potentially reducing the need for adjuvant therapies. Rovera’s innovative integration of robotics and molecular imaging marks him as a rising authority in the next generation of urologic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted PSMA-radioguided Surgery to Assess Surgical Margins and Nodal Metastases in Prostate Cancer Patients: Report on Three Cases Using an Intraoperative PET-CT Specimen Imager
12 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: University of Turin

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago